SCHEMBL3065462

SCHEMBL3065462

Nc1c(F)c(F)c(C=O)c(F)c1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL809345 0.84 VCP (0.33)
SCHEMBL419449 0.81 VCP (0.38)
SCHEMBL1808857 0.78 VCP (0.36)
SCHEMBL22042201 0.77 MEN1 (0.32)
SCHEMBL24834495 0.75
SCHEMBL1809301 0.74 VCP (0.38)
SCHEMBL1378109 0.73
SCHEMBL27886193 0.73 HSD17B10 (0.32)
SCHEMBL6848990 0.73
SCHEMBL2559194 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0984798-B1 DRUG DELIVERY VIA THERAPEUTIC HYDROGELS UROTEQ INC (CA) 2005-10-05 EP claimed
US-7858349-B2 Anti-cancer compounds THE REGENTS OF THE UNIVERSITY OF COLORADO (US) 2010-12-28 US disclosed
US-20100267078-A1 Selective Detection of Proteins that Contain Two or More Alpha-Helical Transmembrane Domains Life Technologies Corporation (US) 2010-10-21 US disclosed
US-20090088454-A1 ANTI-CANCER COMPOUNDS THE REGENTS OF THE UNIVERSITY OF COLORADO (US) 2009-04-02 US disclosed
US-7427496-B2 Anti-cancer compounds THE REGENTS OF THE UNIVERSITY OF COLORADO (US) 2008-09-23 US disclosed
US-20060183772-A1 To inhibit tumor growth in an animal; to induce apoptosis NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2006-08-17 US disclosed
US-20060027455-A1 Selective detection of proteins that contain two or more alpha-helical transmembrane domains MOLECULAR PROBES, INC. 2006-02-09 US disclosed